Takeda Pharmaceutical Co Ltd (TKPHF) SEC Filings — 2024

Filings

• Takeda Pharmaceutical Files 6-K for December 2024 — 6-K · Dec 18, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Dec 13, 2024
• Takeda Pharmaceutical Files 6-K for December 2024 — 6-K · Dec 2, 2024
• Takeda Pharma Files 6-K, Confirms 20-F Reporting — 6-K · Oct 31, 2024
• Takeda Pharmaceutical Files 6-K for September 2024 — 6-K · Sep 26, 2024
• Takeda Pharmaceutical Files 6-K — 6-K · Jul 31, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Jul 10, 2024
• Takeda Pharmaceutical Files 6-K — 6-K · Jul 9, 2024
• Takeda Pharma Files Forms for $3 Billion in New Senior Notes — 6-K · Jul 5, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Jul 2, 2024
• Takeda Pharmaceutical Files July 2024 6-K Report — 6-K · Jul 1, 2024
• Takeda Pharmaceutical Files 6-K — 6-K · Jun 26, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Jun 17, 2024
• Takeda Pharma Files 6-K for June 2024 — 6-K · Jun 11, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Jun 10, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · Jun 7, 2024
• Takeda Pharmaceutical Files June 2024 6-K Report — 6-K · Jun 3, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · May 29, 2024
• Takeda Pharmaceutical Files 6-K Report — 6-K · May 21, 2024
• Takeda Pharma Files 6-K, Confirms 20-F Filing — 6-K · May 9, 2024
• Takeda Pharmaceutical Files 6-K with SEC — 6-K · Apr 19, 2024
• Takeda Pharmaceutical Files Routine 6-K Disclosure — 6-K · Apr 15, 2024
• Takeda Pharma Files 13D/A Amendment on Phathom — SC 13D/A · Apr 10, 2024
• Takeda Pharma Files 13D/A Amendment on Phathom Holdings — SC 13D/A · Apr 1, 2024
• Takeda Pharmaceutical Files 6-K for March 2024 — 6-K · Mar 27, 2024
• Takeda to Launch Global Phase 3 Trials for Narcolepsy Drug TAK-861 — 6-K · Feb 9, 2024
• BlackRock Amends Takeda Pharma Stake, Signals Continued Confidence — SC 13G/A · Feb 6, 2024
• Sumitomo Mitsui Trust Holdings Divests Takeda Voting Power — SC 13G/A · Feb 5, 2024
• Takeda Files Q3 2023 Quarterly Securities Report in English — 6-K · Feb 2, 2024
• Takeda Files 9-Month Financials Ending Dec 31, 2023 — 6-K · Feb 1, 2024
• Takeda Cuts Phathom Stake to 14.9%, Now Holds 10M Shares — SC 13D/A · Jan 25, 2024
• Takeda Pharma Discloses 1.84M Share Stake in Equillium — SC 13G · Jan 19, 2024
• Takeda Pharma Splits with Wholly-Owned Subsidiary for Operational Streamlining — 6-K · Jan 16, 2024